Macular Degeneration
Showing NaN - NaN of 21
Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)
Not yet recruiting
- Geographic Atrophy of the Macula
- Macular Degeneration
- AVD-104
- Sham injection
-
Saint Petersburg, Florida
- +4 more
Apr 20, 2023
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Terminated
- Dry Age-related Macular Degeneration
- +4 more
-
Phoenix, Arizona
- +28 more
Mar 22, 2022
Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)
Completed
- Neovascular Age-related Macular Degeneration
- +3 more
- GEM103
- sham + SoC
-
Phoenix, Arizona
- +22 more
Mar 22, 2022
Natural Progression of Dry Age-related Macular Degeneration
Recruiting
- Dry Age-related Macular Degeneration
- +5 more
-
Phoenix, Arizona
- +65 more
Feb 22, 2021
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Completed
- Dry Age-related Macular Degeneration
- +4 more
- GEM103
-
Phoenix, Arizona
- +11 more
Feb 9, 2021
Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)
Completed
- Macular Degeneration
- Abicipar Pegol
- +2 more
-
Phoenix, Arizona
- +150 more
Jul 16, 2020
Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)
Terminated
- Geographic Atrophy
- Macular Degeneration
- 400 µg Brimonidine Implant
- Sham
-
Phoenix, Arizona
- +40 more
Mar 29, 2019
Macular Degeneration Trial in United States (Abicipar pegol)
Completed
- Macular Degeneration
- Abicipar pegol
-
Gilbert, Arizona
- +17 more
Feb 6, 2018
Macular Degeneration Trial in Australia, Italy, United States (Pazopanib)
Completed
- Macular Degeneration
-
Beverly Hills, California
- +16 more
Oct 31, 2017
Macular Degeneration Trial in Canada, United States (bevasiranib, ranibizumab)
Terminated
- Macular Degeneration
-
Phoenix, Arizona
- +59 more
Sep 29, 2014
Macular Degeneration Trial in Worldwide (rhuFab V2 (ranibizumab))
Completed
- Macular Degeneration
- rhuFab V2 (ranibizumab)
-
Tucson, Arizona
- +81 more
Mar 18, 2014
Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- ranibizumab
- aflibercept injection (VEGF Trap-Eye, BAY86-5321)
-
Birmingham, Alabama
- +187 more
Dec 20, 2012
Macular Degeneration Trial in United States (aflibercept injection (VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- aflibercept injection (VEGF Trap-Eye, BAY86-5321)
-
Phoenix, Arizona
- +17 more
Jan 27, 2012
Choroidal Neovascularization, Macular Degeneration Trial in Canada, United States (verteporfin, ranibizumab, dexamethasone)
Completed
- Choroidal Neovascularization
- Macular Degeneration
- verteporfin
- +2 more
-
Mobile, Alabama
- +25 more
May 31, 2011
Macular Degeneration Trial in United States (MSI-1256F (Squalamine Lactate))
Terminated
- Macular Degeneration
- MSI-1256F (Squalamine Lactate)
-
Boynton Beach, Florida
- +8 more
Nov 27, 2007